10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 2 filers reported holding 10X GENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $316,342 | -9.6% | 5,653 | -33.4% | 0.23% | -15.2% |
Q3 2023 | $350,089 | -41.9% | 8,487 | -21.4% | 0.27% | -32.1% |
Q2 2023 | $602,960 | +4.3% | 10,798 | +4.2% | 0.40% | -2.2% |
Q1 2023 | $578,096 | +48.2% | 10,362 | -3.2% | 0.40% | +25.0% |
Q4 2022 | $390,000 | +39.3% | 10,707 | +9.1% | 0.32% | +36.7% |
Q3 2022 | $280,000 | -46.2% | 9,817 | -14.6% | 0.24% | +99.2% |
Q2 2022 | $520,000 | -14.6% | 11,493 | +43.6% | 0.12% | -71.0% |
Q1 2022 | $609,000 | -41.2% | 8,001 | +15.1% | 0.41% | -41.3% |
Q4 2021 | $1,036,000 | +13.2% | 6,952 | +10.6% | 0.70% | +10.8% |
Q3 2021 | $915,000 | -13.8% | 6,288 | +15.9% | 0.63% | -12.6% |
Q2 2021 | $1,062,000 | +305.3% | 5,425 | +274.7% | 0.72% | +179.2% |
Q1 2021 | $262,000 | – | 1,448 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |